Novartis said two brothers who were senior researchers at the company were responsible for the manipulation of data behind its $2.1 million gene therapy, Zolgensma, according to The Wall Street Journal.

Catalyst Pharmaceuticals' stocks dropped substantially Sept. 23 for the second time in two weeks, though the company has no explanation, according to STAT.

The FDA announced Sept. 23 updated guidelines for developing drugs to treat amyotrophic lateral sclerosis.

Sept. 25 marks this year's World Pharmacist Day, which aims to recognize the role pharmacists play in improving health throughout the world. 

The United States Pharmacopeia is postponing the effective dates of several revised compounding standards because of appeals against them, according to a Sept. 23 American Hospital Association news release.

A report released Sept. 23 by the House Ways & Means Committee shows that Americans pay on average nearly four times more for prescription drugs than 11 economically similar countries.

Drugmakers have spent millions of dollars on ads and lobbying to attack proposals that would jeopardize their pricing power, according to The Wall Street Journal.

Sandoz, the generic unit of Novartis, has expanded the recall of its heartburn medications containing ranitidine to the U.S., according to STAT. 

Akcea Therapeutics, a Boston-based biotechnology company, has replaced three of its top executives.

Congress will hold a hearing Sept. 25 to discuss four proposed drug-pricing plans.